UNSPSC 51391701: Butopamine
Commodity
Code facts
- Part of
-
-
51000000
-
51390000
- 51391700
-
51390000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51391701
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes a beta-adrenergic agonist with the molecular formula C18H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZX7907IE2H, chemically known as benzenemethanol, 4-hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)-, (r-(r*,r*)) but generally known as butopamine, which bears US NIH Compound Identifier 68556. European Medicines Agency schedules Butopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06031MIG.
Read the full definition
The term BUTOPAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). BUTOPAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butopamine under HS 29225000 and SITC 51467. As of Q4 2014, BUTOPAMINE remains the US FDA Preferred Term for this commodity. Butopamine bears US NLM identifiers UMLS ID C0054265 and NCI Concept Code C81649. SMILES: OC(CNC(CCC1CCC(O)CC1)C)C1CCC(O)CC1.
About UNSPSC 51391701
UNSPSC 51391701 Butopamine is a Commodity code that in state and local procurement covers pharmaceutical products and related health-system supplies. Recent opportunities show state and local governments purchasing naloxone, drug deactivation systems, and related pharmacy benefit program infrastructure under this code. Issuing bodies are primarily county health departments and state health and human services commissions, each procuring these products to support community health and emergency response initiatives. The mix reflects both direct product acquisition by operational health agencies and strategic procurement by state-level pharmacy benefit administrators seeking to optimize prescription fulfillment and cost management across multiple jurisdictions.
Seminole County, Florida posted an IFB (Solicitation IFB60459723LAS, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and an initial two-year contract term plus one-year renewal option. The Texas Health and Human Services Commission issued an RFI (HHS0017013, posted April 3, 2026) to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, designed to evaluate vendors' capacity for direct contracting with self-insured employer plans and state agencies outside traditional pharmacy benefit manager arrangements. Geographic activity centers on Florida and Texas; the code shows limited recent activity overall, with only two posted opportunities in the recent window.
Quick answers
What is UNSPSC 51391701?
UNSPSC 51391701 is Butopamine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51391701?
UNSPSC 51391701 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51391701
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code